Search research articles
Contact Us
Filters
Showing results (121-130 of 158) with videos related to
Page
of 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
December 26, 2014
Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo
Rituparna Das, Rakesh Verma, Mario Sznol, et al.
British Journal of Haematology
|
November 11, 1999
High-dose therapy with autologous haemopoietic stem cell support for Waldenström's macroglobulinaemia
R Desikan, M Dhodapkar, D Siegel, et al.
Bone Marrow Transplantation
|
March 14, 2000
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone
K R Desikan, G Tricot, M Dhodapkar, et al.
Cancer Research
|
August 28, 2001
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine
J Banchereau, A K Palucka, M Dhodapkar, et al.
Nature Methods
|
November 3, 2023
Causal identification of single-cell experimental perturbation effects with CINEMA-OT
Mingze Dong, Bao Wang, Jessica Wei, et al.
The Journal of Clinical Investigation
|
January 9, 2018
Early B cell changes predict autoimmunity following combination immune checkpoint blockade
Rituparna Das, Noffar Bar, Michelle Ferreira, et al.
Blood Cancer Journal
|
March 26, 2016
Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120)
X Papanikolaou, A Rosenthal, M Dhodapkar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 20, 2025
Plasma Cytokine and Chemokine Profiles Predict Efficacy and Toxicity of Anti-CD19 CAR-T Cell Therapy in Large B-Cell Lymphoma
Fanyuan Zeng, Hanwen Zhang, Shuhua Wang, et al.
Blood Advances
|
February 6, 2025
Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myeloma
Sayalee V Potdar, Shivani Kapadia, Maryam I Azeem, et al.
Nature Cancer
|
August 26, 2024
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial
Shambavi Richard, Alexander M Lesokhin, Barry Paul, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 158) with videos related to
Sort By:
Page
of 16
Journal of Immunology (Baltimore, Md. : 1950)
|
December 26, 2014
Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo
Rituparna Das, Rakesh Verma, Mario Sznol, et al.
British Journal of Haematology
|
November 11, 1999
High-dose therapy with autologous haemopoietic stem cell support for Waldenström's macroglobulinaemia
R Desikan, M Dhodapkar, D Siegel, et al.
Bone Marrow Transplantation
|
March 14, 2000
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone
K R Desikan, G Tricot, M Dhodapkar, et al.
Cancer Research
|
August 28, 2001
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine
J Banchereau, A K Palucka, M Dhodapkar, et al.
Nature Methods
|
November 3, 2023
Causal identification of single-cell experimental perturbation effects with CINEMA-OT
Mingze Dong, Bao Wang, Jessica Wei, et al.
The Journal of Clinical Investigation
|
January 9, 2018
Early B cell changes predict autoimmunity following combination immune checkpoint blockade
Rituparna Das, Noffar Bar, Michelle Ferreira, et al.
Blood Cancer Journal
|
March 26, 2016
Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120)
X Papanikolaou, A Rosenthal, M Dhodapkar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 20, 2025
Plasma Cytokine and Chemokine Profiles Predict Efficacy and Toxicity of Anti-CD19 CAR-T Cell Therapy in Large B-Cell Lymphoma
Fanyuan Zeng, Hanwen Zhang, Shuhua Wang, et al.
Blood Advances
|
February 6, 2025
Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myeloma
Sayalee V Potdar, Shivani Kapadia, Maryam I Azeem, et al.
Nature Cancer
|
August 26, 2024
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial
Shambavi Richard, Alexander M Lesokhin, Barry Paul, et al.
Page
of 16